Shares of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Get Free Report) traded up 5.4% during mid-day trading on Tuesday . The company traded as high as $24.07 and last traded at $23.90. 138,161 shares were traded during trading, a decline of 50% from the average session volume of 277,268 shares. The stock had previously closed at $22.68.
Analyst Upgrades and Downgrades
A number of analysts have weighed in on KMTS shares. Wall Street Zen raised shares of Kestra Medical Technologies from a "sell" rating to a "hold" rating in a report on Saturday. Wells Fargo & Company reduced their target price on shares of Kestra Medical Technologies from $28.00 to $27.00 and set an "overweight" rating for the company in a research note on Thursday, July 17th. Five equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $27.33.
View Our Latest Stock Report on Kestra Medical Technologies
Kestra Medical Technologies Stock Performance
The business has a fifty day simple moving average of $17.33 and a two-hundred day simple moving average of $19.99. The company has a debt-to-equity ratio of 0.23, a quick ratio of 6.72 and a current ratio of 6.84.
Institutional Investors Weigh In On Kestra Medical Technologies
A number of hedge funds have recently made changes to their positions in KMTS. Yu Fan acquired a new position in Kestra Medical Technologies in the first quarter valued at about $56,880,000. T. Rowe Price Investment Management Inc. acquired a new position in shares of Kestra Medical Technologies in the 1st quarter worth approximately $56,613,000. Omega Fund Management LLC acquired a new stake in Kestra Medical Technologies during the 1st quarter valued at $44,754,000. Alliancebernstein L.P. increased its holdings in Kestra Medical Technologies by 10.8% during the 2nd quarter. Alliancebernstein L.P. now owns 1,312,085 shares of the company's stock valued at $21,754,000 after purchasing an additional 128,312 shares in the last quarter. Finally, Eventide Asset Management LLC boosted its stake in Kestra Medical Technologies by 285.7% in the second quarter. Eventide Asset Management LLC now owns 1,060,557 shares of the company's stock worth $17,584,000 after purchasing an additional 785,557 shares in the last quarter.
About Kestra Medical Technologies
(
Get Free Report)
We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.
Recommended Stories
Before you consider Kestra Medical Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kestra Medical Technologies wasn't on the list.
While Kestra Medical Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
